Pixium Vision announces participation in investor

Pixium Vision announces participation in investor conferences and occasions in October 2022

Paris, France, October 4, 2022 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris – FR0011950641; Mnemo: ALPIX), a bioelectronics firm that develops modern bionic imaginative and prescient programs to allow sufferers who’ve misplaced their sight to reside extra impartial lives, announces as we speak that senior administration will take part in the next investor occasions in October 2022:

• Biotech Agora, October 12, Paris
  Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer will host an investor cocktail reception in Paris, held in French. Participation is by invitation solely.

• HealthTech Innovation Days, October 13 – 14, Paris
  Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer will attend in particular person. Registration for the convention is open right here.

• European Midcap Event, October 17 – 18, Paris
  Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer will attend in particular person. Registration for the convention is open right here.

About Pixium Vision

Pixium Vision is making a world of bionic imaginative and prescient for individuals who have misplaced their sight, enabling them to regain visible notion and larger autonomy. Pixium Vision’s bionic imaginative and prescient programs are related to a surgical intervention and a rehabilitation interval. Prima System sub-retinal miniature photovoltaic wi-fi implant is in medical testing for sufferers who’ve misplaced their sight attributable to outer retinal degeneration, initially for atrophic dry age-related macular degeneration (dry AMD). Pixium Vision collaborates intently with tutorial and analysis companions, together with a few of the most prestigious imaginative and prescient analysis establishments in the world, corresponding to Stanford University in California, Institut de la Vision in Paris, Moorfields Eye Hospital in London, Institute of Ocular Microsurgery (IMO) in Barcelona, University hospital in Bonn, and UPMC in Pittsburgh, PA. The firm is EN ISO 13485 licensed and qualifies as “Entreprise Innovante” by Bpifrance.

Forward-Looking Statements. This press launch incorporates sure forward-looking statements. Although the Company believes its expectations are primarily based on affordable assumptions, these forward-looking statements are topic to quite a few dangers and uncertainties, which may trigger precise outcomes to vary materially from these anticipated. For a dialogue of dangers and uncertainties which may trigger the Company’s precise outcomes, monetary situation, efficiency or achievements to vary from these contained in the ahead trying statements, please confer with the Risk Factors (“Facteurs de Risques”) part of the Company’s 2021 Half-Year Financial Report and different paperwork the Company recordsdata with the AMF, which is accessible on the AMF web site (www.amf- france.org) or on the Company’s web site.

For extra info: http://www.pixium-vision.com/fr

Follow us on @PixiumVision; www.fb.com/pixiumvision

               www.linkedin.com/firm/pixium-vision  

Contacts